New Ray Medicine International Holding Limited

SEHK:6108 Stock Report

Market Cap: HK$85.3m

New Ray Medicine International Holding Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for New Ray Medicine International Holding.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth21.5%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Lacklustre Performance Is Driving New Ray Medicine International Holding Limited's (HKG:6108) 34% Price Drop

Jan 26
Lacklustre Performance Is Driving New Ray Medicine International Holding Limited's (HKG:6108) 34% Price Drop

There's Reason For Concern Over New Ray Medicine International Holding Limited's (HKG:6108) Price

Jun 08
There's Reason For Concern Over New Ray Medicine International Holding Limited's (HKG:6108) Price

We're Keeping An Eye On New Ray Medicine International Holding's (HKG:6108) Cash Burn Rate

Mar 29
We're Keeping An Eye On New Ray Medicine International Holding's (HKG:6108) Cash Burn Rate

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as New Ray Medicine International Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SEHK:6108 - Analysts future estimates and past financials data (HKD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202436-13-12-12N/A
3/31/202443-18-29-29N/A
12/31/202350-22-45-45N/A
9/30/202335-46-53-48N/A
6/30/202361-70-60-51N/A
3/31/202376-74-34-26N/A
12/31/202290-78-90N/A
9/30/2022135-52-14N/A
6/30/2022180-2588N/A
3/31/2022258-14-25-25N/A
12/31/2021335-3-58-58N/A
9/30/2021307-17-76-76N/A
6/30/2021278-32-94-94N/A
3/31/2021206-51-63-63N/A
12/31/2020133-70-32-32N/A
9/30/2020133-71-9-8N/A
6/30/2020133-731415N/A
3/31/2020126-58-22-21N/A
12/31/2019119-44-58-57N/A
9/30/2019188-16-35-30N/A
6/30/201925811-12-4N/A
3/31/2019315221927N/A
12/31/2018372335058N/A
9/30/2018326-3-15-11N/A
6/30/2018280-38-79-79N/A
3/31/2018258-72N/A-94N/A
12/31/2017235-105N/A-108N/A
9/30/2017241-89N/A-58N/A
6/30/2017247-72N/A-7N/A
3/31/2017236-46N/A-14N/A
12/31/2016225-20N/A-21N/A
9/30/2016226-11N/A-24N/A
6/30/2016227-1N/A-27N/A
3/31/20162507N/AN/AN/A
12/31/201525315N/A-3N/A
9/30/201525726N/AN/AN/A
6/30/201524934N/A7N/A
3/31/201523334N/AN/AN/A
12/31/201420730N/A15N/A
9/30/201420833N/AN/AN/A
6/30/201419727N/A9N/A
3/31/201418224N/AN/AN/A
12/31/201319317N/A22N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 6108's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if 6108's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 6108's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 6108's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 6108's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 6108's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y